search
Back to results

Stop At One Stockholm (SAOS)- Secondary Fracture Prevention Through Active Patient Identification and Staff Education. (SAOS)

Primary Purpose

Osteoporotic Fractures, Osteoporosis, Osteoporosis Risk

Status
Active
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Support on dentification and treatment of patients with high risk of osteoporotic fractures
Sponsored by
Helena Salminen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Osteoporotic Fractures focused on measuring Organization & administration, Secondary prevention, Bone Density Conservation Agents

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

All primary health care centers (PHCCs) in Stockholm County were invited to participate in the study. The goal was to include at least 40

Inclusion Criteria for referral of patients to PHCC:

  • Patient has a diagnose at a medical care unit within Stockholm county on a low energy fracture of hip, pelvis, spine, proximal humerus och distal radius between three months before study start an end of study.
  • Patient is enlisted at one of the PHCCs in the interventional arm of the study
  • Patent is aged 60 years or older

Exclusion Criteria:

  • The patient has after the index fracture, already been referred to the correct primary health care center for secondary fracture prevention.

Sites / Locations

  • Karolinska Instititet

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Intervention

Control

Arm Description

Multiprofessional education for health professionals in primary care on secondary prevention of osteoporotic fractures. Identification and referral of patients with recent osteoporotic fracture.

No intervention from study. No restrictions regarding education or the local organization of care for the prevention of osteoporotic fractures.

Outcomes

Primary Outcome Measures

Proportion of participants treated with bone specific drugs after first fragility fracture at different points in time up to two years after inclusion.
Participants are included in the study at the date of their first fragility fracture within the study period. The proportion of participants treated with bone-specific drugs any time since the fracture date, will be measured every 6 months during the study period.

Secondary Outcome Measures

Proportion of participants treated with calcium and vitamin D but not bone specific drugs after first fragility fracture at different points in time after inclusion up to two years after inclusion.
Participants are included in the study at the date of their first fragility fracture within the study period. The proportion of participants treated with Calcium and vitamin D supplements but not simultaneously with bone-specific drugs at any time since the fracture date, will be measured until two years after inclusion.

Full Information

First Posted
September 17, 2020
Last Updated
April 5, 2022
Sponsor
Helena Salminen
Collaborators
Region Stockholm
search

1. Study Identification

Unique Protocol Identification Number
NCT04565743
Brief Title
Stop At One Stockholm (SAOS)- Secondary Fracture Prevention Through Active Patient Identification and Staff Education.
Acronym
SAOS
Official Title
Stop At One Stockholm: Co-operation Between Health Care Providers and Medical Education in Primary Health Care to Prevent Falls and Fractures in the Elderly
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
February 1, 2018 (Actual)
Primary Completion Date
April 2023 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Helena Salminen
Collaborators
Region Stockholm

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a study on the effects of education on secondary fracture prevention in primary health care centers (PHCC) and referral from hospitals to these PHCC of patients with recent fragility fractures. The design is Cluster-randomized controlled study with two arms. 40 primary health care centers (PHCC) are included, each PHCC constitutes a cluster. The intervention group contains 20 PHCCs and the control group of the remaining 20 PHCCs. The educational part of the intervention is divided into three sessions; one web based course succeeded by two multiprofessional seminars with six months interval. During the intervention period patients enlisted at the intervention PHCCs, aged 60 or more who are diagnosed on a fragility fracture are referred to their respective PHCC. The primary outcome are the proportions of patients who receive bone specific treatment after their fracture in the intervention group compared to the control group.
Detailed Description
Fragility fractures are in this study defined as a fracture of the spine, hip, pelvis, proximal humerus och distal radius caused by low energy trauma. A trauma not exceeding the force implied on the body from a fall from standing height on a flat surface, is regarded to be a low energy trauma. The educational intervention targets general practitioners and nurses from the PHCC as well as physiotherapists, occupational therapists and dietitians from a nearby rehabilitation centre. All professions go through the same web course before educational session #1 which is held at the PHCC. The web course includes basic knowledge about risk factors for fragility fractures At session #1 all professions first participate in a common seminar of 45 minutes. After that physicians, nurses and rehabilitation related professions each have an additional seminar of 45 minutes, that means three separate seminars. Three teachers lead the seminars; a specialist in family medicine, a nurse specialized in primary care and a physiotherapist. They are all present during all of the seminars at each PHCC and the same three individuals leads the seminars at all PHCCs. The seminars focus on identification of persons at high risk of fracture and different methods to lower that risk. The importance of multiprofessional care for these patients is stressed. The participants are given opportunity to discuss how they might facilitate cooperation between the different health vare professions. Development of local routines for multiprofessional care is encouraged. Educational session #2 is held approximally 6 months after session #1. Session #2 invites the same health care professionals as session #1. There are three parts. A first part of 45 minutes for the physicians and nurses. A second part of 45 minutes where personnel from the rehabilitation center joins. The third part of 45 minutes incudes just the rehabilitation personnel. At session #2 includes a short review of the contents discussed in session #1. The focus however is on the development of new local routines to secure the ability for patients with a high risk of fracture to be offered multiprofessional care. What needs to be done and who does what at your PHCC/rehabilitation center? The participants also get feedback on the number of patients being treated with bone-specific drugs before and after the start of the intervention. Inclusion of patients stops at december 1 2020. Referrals to the PHCC of the patients included last will be conducted during January 2021. Primary outcome data is gathered at each PHCC from the medical journals of the enlisted patients aged >60 with fragility fractures. Data includes the time frame one year before start of study, until two years after the last patient was incuded. Secondary outcomes, fractures and fall related injuries will be collected from National health care registers, three and five years after the last patient was included.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoporotic Fractures, Osteoporosis, Osteoporosis Risk
Keywords
Organization & administration, Secondary prevention, Bone Density Conservation Agents

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Cluster randomized controlled study. 40 clusters with an estimated cluster size of 90 participating individuals in each cluster.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
3600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Active Comparator
Arm Description
Multiprofessional education for health professionals in primary care on secondary prevention of osteoporotic fractures. Identification and referral of patients with recent osteoporotic fracture.
Arm Title
Control
Arm Type
No Intervention
Arm Description
No intervention from study. No restrictions regarding education or the local organization of care for the prevention of osteoporotic fractures.
Intervention Type
Behavioral
Intervention Name(s)
Support on dentification and treatment of patients with high risk of osteoporotic fractures
Intervention Description
Education for primary care health care professionals and referral of patients with recent osteoporotic fracture.
Primary Outcome Measure Information:
Title
Proportion of participants treated with bone specific drugs after first fragility fracture at different points in time up to two years after inclusion.
Description
Participants are included in the study at the date of their first fragility fracture within the study period. The proportion of participants treated with bone-specific drugs any time since the fracture date, will be measured every 6 months during the study period.
Time Frame
Two year after inclusion of study patcipant
Secondary Outcome Measure Information:
Title
Proportion of participants treated with calcium and vitamin D but not bone specific drugs after first fragility fracture at different points in time after inclusion up to two years after inclusion.
Description
Participants are included in the study at the date of their first fragility fracture within the study period. The proportion of participants treated with Calcium and vitamin D supplements but not simultaneously with bone-specific drugs at any time since the fracture date, will be measured until two years after inclusion.
Time Frame
Two years
Other Pre-specified Outcome Measures:
Title
Incidence of new fractures and fall related injuries after index fracture.
Description
Participants are included in the study at the date of their first fragility fracture within the study period. Mortality, fractures and other fall related injuries are collected from National health care registers for the period three and five years after the last patient was included in the study. The follow up time will thus be different for different participants depending on the date of inclusion.
Time Frame
Five years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
All primary health care centers (PHCCs) in Stockholm County were invited to participate in the study. The goal was to include at least 40 Inclusion Criteria for referral of patients to PHCC: Patient has a diagnose at a medical care unit within Stockholm county on a low energy fracture of hip, pelvis, spine, proximal humerus och distal radius between three months before study start an end of study. Patient is enlisted at one of the PHCCs in the interventional arm of the study Patent is aged 60 years or older Exclusion Criteria: The patient has after the index fracture, already been referred to the correct primary health care center for secondary fracture prevention.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Helena Salminen, MD, Ass Prof
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Karolinska Instititet
City
Huddinge
State/Province
Stockholm
ZIP/Postal Code
14183
Country
Sweden

12. IPD Sharing Statement

Learn more about this trial

Stop At One Stockholm (SAOS)- Secondary Fracture Prevention Through Active Patient Identification and Staff Education.

We'll reach out to this number within 24 hrs